Hilde Vranckx

1.2k total citations
9 papers, 594 citations indexed

About

Hilde Vranckx is a scholar working on Hematology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hilde Vranckx has authored 9 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 4 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hilde Vranckx's work include Acute Myeloid Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Hilde Vranckx is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Hilde Vranckx collaborates with scholars based in Belgium, Netherlands and Switzerland. Hilde Vranckx's co-authors include Michel Stul, Anne Hagemeijer, Maria Dêbiec‐Rychter, Bartosz Wasąg, A. van Oosterom, Raf Sciot, Peter Marynen, Nicole Mentens, Johannes Roesel and Hans Prenen and has published in prestigious journals such as Gastroenterology, Leukemia and Modern Pathology.

In The Last Decade

Hilde Vranckx

8 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hilde Vranckx Belgium 6 395 345 168 154 112 9 594
Hema Sundar United States 5 826 2.1× 745 2.2× 56 0.3× 564 3.7× 104 0.9× 6 949
Su Y. Kim United States 9 85 0.2× 99 0.3× 87 0.5× 60 0.4× 67 0.6× 11 391
P.D. Simmonds United Kingdom 9 152 0.4× 79 0.2× 13 0.1× 215 1.4× 31 0.3× 13 469
Peter Forsyth United Kingdom 7 67 0.2× 50 0.1× 130 0.8× 32 0.2× 35 0.3× 14 391
Daniele Bertoloni Italy 9 41 0.1× 105 0.3× 104 0.6× 43 0.3× 35 0.3× 14 432
Jasmien Cornillie Belgium 14 111 0.3× 330 1.0× 18 0.1× 73 0.5× 65 0.6× 27 471
Sheila M. Dobin United States 12 22 0.1× 266 0.8× 38 0.2× 50 0.3× 28 0.3× 36 442
Lothar Veits Germany 11 52 0.1× 100 0.3× 18 0.1× 136 0.9× 76 0.7× 28 394
Avery A. Sandberg United States 10 21 0.1× 164 0.5× 40 0.2× 22 0.1× 23 0.2× 13 408
Constantinos Tsatalas Greece 9 59 0.1× 36 0.1× 127 0.8× 41 0.3× 20 0.2× 18 441

Countries citing papers authored by Hilde Vranckx

Since Specialization
Citations

This map shows the geographic impact of Hilde Vranckx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilde Vranckx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilde Vranckx more than expected).

Fields of papers citing papers by Hilde Vranckx

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hilde Vranckx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilde Vranckx. The network helps show where Hilde Vranckx may publish in the future.

Co-authorship network of co-authors of Hilde Vranckx

This figure shows the co-authorship network connecting the top 25 collaborators of Hilde Vranckx. A scholar is included among the top collaborators of Hilde Vranckx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hilde Vranckx. Hilde Vranckx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Vranckx, Hilde, et al.. (2021). Next generation sequencing in therapy-related myeloid neoplasms compared to de novo myeloid neoplasms. Acta Clinica Belgica. 77(3). 658–663.
2.
Dêbiec‐Rychter, Maria, Jan Cools, Herlinde Dumez, et al.. (2005). Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants. Gastroenterology. 128(2). 270–279. 396 indexed citations
3.
Wasąg, Bartosz, Maria Dêbiec‐Rychter, Patrick Pauwels, et al.. (2004). Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site. Modern Pathology. 17(8). 889–894. 80 indexed citations
4.
Prijck, Bernard De, Hilde Vranckx, Rolf Marschalek, et al.. (2001). Cryptic t(4;11) encoding MLL-AF4 due to insertion of 5′ MLL sequences in chromosome 4. Leukemia. 15(4). 595–600. 28 indexed citations
5.
Zelderen‐Bhola, Shama L. van, et al.. (2000). A DNA probe combination for improved detection of MLL/11q23 breakpoints by double-color interphase-FISH in acute leukemias. Pure Amsterdam UMC. 1 indexed citations
6.
Smetsers, Toon F.C.M., Rob W. M. van Soest, Michel Stul, et al.. (2000). A DNA probe combination for improved detection of MLL/11q23 breakpoints by double-color interphase-FISH in acute leukemias. Genes Chromosomes and Cancer. 28(1). 14–14. 5 indexed citations
7.
Mancini, Marco, Michele Cedrone, Daniela Diverio, et al.. (2000). Use of dual-color interphase FISH for the detection of inv(16) in acute myeloid leukemia at diagnosis, relapse and during follow-up: a study of 23 patients. Leukemia. 14(3). 364–368. 19 indexed citations
8.
Smetsers, Toon F.C.M., Michel Stul, Hilde Vranckx, et al.. (2000). A DNA probe combination for improved detection ofMLL/11q23 breakpoints by double-color interphase-FISH in acute leukemias. Genes Chromosomes and Cancer. 28(1). 14–22. 44 indexed citations
9.
Dierlamm, Judith, Michel Stul, Hilde Vranckx, et al.. (1998). FISH identifies inv(16)(p13q22) masked by translocations in three cases of acute myeloid leukemia. Genes Chromosomes and Cancer. 22(2). 87–94. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hema Sundar Breakdown of academic impact, for papers by Su Y. Kim Breakdown of academic impact, for papers by P.D. Simmonds Breakdown of academic impact, for papers by Peter Forsyth Breakdown of academic impact, for papers by Daniele Bertoloni Breakdown of academic impact, for papers by Jasmien Cornillie Breakdown of academic impact, for papers by Sheila M. Dobin Breakdown of academic impact, for papers by Lothar Veits Breakdown of academic impact, for papers by Avery A. Sandberg Breakdown of academic impact, for papers by Constantinos Tsatalas
Rankless by CCL
2026